Page last updated: 2024-08-21

thymoquinone and 2019 Novel Coronavirus Disease

thymoquinone has been researched along with 2019 Novel Coronavirus Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's7 (100.00)2.80

Authors

AuthorsStudies
Chen, H; Cheng, J; Du, J; Fu, J; Fu, S; Guo, K; He, J; He, T; Li, D; Li, T; Liu, S; Liu, X; Liu, Z; Qian, J; Song, B; Tan, Q; Zhang, L; Zhou, B1
Cheng, J; Fu, J; He, J; Li, T; Liu, S; Liu, X; Liu, Z; Mei, Z; Tan, Q; Wang, K; Wei, C1
Khan, MA; Younus, H1
Amin, NS; El Tayebi, HM; Elgohary, S; Elkhodiry, AA; Stein, U1
Badary, OA; Hamza, MS; Tikamdas, R1
Ghafari, S; Khazdair, MR; Sadeghi, M1
Ahmad, A; Alkharfy, KM; Raish, M1

Reviews

4 review(s) available for thymoquinone and 2019 Novel Coronavirus Disease

ArticleYear
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
    Cells, 2021, 02-02, Volume: 10, Issue:2

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Benzoquinones; Cell Line, Tumor; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endoplasmic Reticulum Chaperone BiP; Humans; Mice; Neoplasms; Rats

2021
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Comorbidity; COVID-19; COVID-19 Drug Treatment; Epigenesis, Genetic; Humans; Molecular Docking Simulation; SARS-CoV-2

2021
Possible therapeutic effects of
    Pharmaceutical biology, 2021, Volume: 59, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Benzoquinones; COVID-19; COVID-19 Drug Treatment; Cytokines; Humans; Immune System; Inflammation Mediators; Lung; Nigella sativa; Plant Extracts; SARS-CoV-2

2021
The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19.
    Vascular pharmacology, 2021, Volume: 141

    Topics: Animals; Antiviral Agents; Benzoquinones; Cardiotonic Agents; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2

2021

Other Studies

3 other study(ies) available for thymoquinone and 2019 Novel Coronavirus Disease

ArticleYear
Impact of
    Molecules (Basel, Switzerland), 2022, Nov-01, Volume: 27, Issue:21

    Topics: Adenosine; COVID-19; COVID-19 Drug Treatment; Humans; Lung Neoplasms; Male; Mutation; Prognosis; Prostatic Neoplasms; SARS-CoV-2; Serine Endopeptidases

2022
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17.
    Molecules (Basel, Switzerland), 2022, Dec-19, Volume: 27, Issue:24

    Topics: ADAM17 Protein; Angiotensin-Converting Enzyme 2; Antiviral Agents; COVID-19; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2

2022
Potential Implications of Black Seed and its Principal Constituent Thymoquinone in the Treatment of COVID-19 Patients.
    Current pharmaceutical biotechnology, 2021, Volume: 22, Issue:10

    Topics: Benzoquinones; COVID-19; Cytokines; Humans; SARS-CoV-2; Seeds

2021